Patents by Inventor David W. Stroman

David W. Stroman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lincomycin nucleotides
    Patent number: 4383109
    Abstract: Novel and useful ribonucleotides of analogs of the well known antibiotics lincomycin and clindamycin. These ribonucleotides are unexpectedly highly active against Streptococcus hemolyticus and Staphylococcus aureus in vivo.
    Type: Grant
    Filed: April 20, 1981
    Date of Patent: May 10, 1983
    Assignee: The Upjohn Company
    Inventors: Alexander D. Argoudelis, David W. Stroman
  • Process for treating malaria
    Patent number: 4368193
    Abstract: A process for treating a protozoan disease, for example, malaria, by the systemic administration to a subject hosting a malarial parasite of the 3-(5'-ribonucleotide) of a novel analog of the well-known antibiotics lincomycin and clindamycin. The analogs are prepared by condensing a cyclic acid with a sugar amine. The 3-ribonucleotides of these analogs can be prepared by microbiological transformation procedures.
    Type: Grant
    Filed: April 20, 1981
    Date of Patent: January 11, 1983
    Assignee: The Upjohn Company
    Inventors: Alexander D. Argoudelis, David W. Stroman